IGC Pharma, Inc. — Director's Dealing 2014

Nov 20, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2014-10-16

Reporting Person: SHENOY SUDHAKAR V (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-10-16	Common Stock	A	250000	—	Acquired	355000	Direct
2014-10-16	Common Stock	A	50000	—	Acquired	405000	Direct

Footnotes

F1: Represents shares of Restricted Stock awarded pursuant to a special grant approved by the Issuer's shareholders at the 2014 Annual Meeting of Stockholders. The shares vest upon certain performance metrics being achieved.

F2: Represents shares of Common Stock awarded pursuant to the Issuer's 2008 Omnibus Incentive Plan.